Paperpal Prime Logo

Hematology, Transfusion and Cell Therapy : Impact Factor & More

eISSN: 2531-1387pISSN: 2531-1379
JournalOpen Access

Key Metrics

CiteScore
2
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • DOAJ DOAJ
Overview
Publisher Elsevier
Language English
Publication Time30
Editorial Review ProcessDouble blind peer review
General Details
LanguageEnglish
Society/Institute/SponsorAssociação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Sociedade Brasileira de Transplante de Medula Óssea (SBTMO), Associazione Italo-Brasiliana di Ematologia (AIBE), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE)
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 30
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble blind peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Hematology, Transfusion and Cell Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Hematology, Transfusion and Cell Therapy

In vitro compatibility of whole blood with commonly used medications in the pediatric trauma setting.
  • 6 Aug 2026
  • Hematology, transfusion and cell therapy
Association between serum biomarkers and clinical stage in treatment-naïve chronic lymphocytic leukemia.
  • 6 Aug 2026
  • Hematology, transfusion and cell therapy
Evaluation of salivary flow in patients following hematopoietic stem cell transplantation: a retrospective study.
  • 6 Aug 2026
  • Hematology, transfusion and cell therapy
A rare large homozygous deletion of the HFE gene in a patient with hemochromatosis: a case report.
  • 6 Aug 2026
  • Hematology, transfusion and cell therapy
CD30 expression in diffuse large B-cell lymphoma and primary mediastinal lymphoma: frequency, association with prognostic factors, and impact on survival.
  • 5 Aug 2026
  • Hematology, transfusion and cell therapy
Improving engraftment in autologous hematopoietic stem cell transplantation: comparing pegfilgrastim with filgrastim in an outpatient setting.
  • 30 Jul 2026
  • Hematology, transfusion and cell therapy
In vitro compatibility of whole blood with commonly used medications in the pediatric trauma setting.
  • 6 Aug 2026
  • Hematology, transfusion and cell therapy
Association between serum biomarkers and clinical stage in treatment-naïve chronic lymphocytic leukemia.
  • 6 Aug 2026
  • Hematology, transfusion and cell therapy
Evaluation of salivary flow in patients following hematopoietic stem cell transplantation: a retrospective study.
  • 6 Aug 2026
  • Hematology, transfusion and cell therapy
A rare large homozygous deletion of the HFE gene in a patient with hemochromatosis: a case report.
  • 6 Aug 2026
  • Hematology, transfusion and cell therapy
CD30 expression in diffuse large B-cell lymphoma and primary mediastinal lymphoma: frequency, association with prognostic factors, and impact on survival.
  • 5 Aug 2026
  • Hematology, transfusion and cell therapy
Improving engraftment in autologous hematopoietic stem cell transplantation: comparing pegfilgrastim with filgrastim in an outpatient setting.
  • 30 Jul 2026
  • Hematology, transfusion and cell therapy

FAQs on Hematology, Transfusion and Cell Therapy